Bain Capital Seals $3.3 Billion Deal for Mitsubishi Tanabe Pharma
Deal News | Feb 07, 2025 | Ropes & Gray
Ropes & Gray represented Bain Capital in its acquisition of Mitsubishi Tanabe Pharma Corporation, a prominent carve-out deal from Mitsubishi Chemical Group Corporation. The transaction, valued at $3.3 billion, was announced on February 7 and involves Bain Capital's Private Equity teams in Asia and North America, along with their Life Sciences team. Bain Capital, founded in 1984, is a major global private investment firm with significant assets under management, while Mitsubishi Tanabe Pharma Corporation, originating in 1678, is a distinguished entity in the pharmaceutical industry focused on ethical pharmaceuticals. The deal highlights the strategic involvement of Ropes & Gray's Tokyo and London teams, guiding Bain Capital through the private equity and antitrust aspects, respectively.
Sectors
- Pharmaceuticals
- Private Equity
Geography
- Japan – Mitsubishi Tanabe Pharma Corporation is headquartered in Osaka, Japan, and is a historic name in the country's pharmaceutical sector.
- United States – Bain Capital, the acquiring firm, is a global private investment company with substantial operations in North America.
Industry
- Pharmaceuticals – The acquisition involves Mitsubishi Tanabe Pharma Corporation, which operates in the pharmaceutical sector, focusing on ethical pharmaceuticals.
- Private Equity – Bain Capital, a private equity firm, is the acquiring entity in this transaction, highlighting the involvement of the private equity industry.
Financials
- 510 billion JPY ($3.3 billion) – The valuation of the acquisition deal for Mitsubishi Tanabe Pharma Corporation.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Bain Capital | Acquiring Company | Company | A leading global private investment firm with extensive assets under management. |
| Mitsubishi Tanabe Pharma Corporation | Target Company | Company | A historic pharmaceutical company, originally part of Mitsubishi Chemical Group Corporation. |
| Mitsubishi Chemical Group Corporation | Selling Company | Company | The parent company from which Mitsubishi Tanabe Pharma Corporation is being carved out. |
| Ropes & Gray | Legal Advisor | Company | A law firm representing Bain Capital in the transaction. |